October 2025

ACC raises red flags over telehealth, payment reform and the cardiologist shortage ()
COVID-19, other infections linked to major cardiovascular risks—researchers push for vaccination ()
How to minimize bleeding risks after TAVR ()
Novo Nordisk, Pfizer enter bidding war for biotech startup—and it is getting ugly ()
Private equity-backed Medline files for IPO ()
Key takeaways for interventional cardiology from TCT 2025 ()
More good news for renal denervation: FDA-approved systems linked to positive long-term data ()
Nearly 600K bottles of blood pressure drug recalled due to carcinogen risk ()
Patient sues Abbott after early heart valve replacement ()
FDA clears new AI-enabled coronary plaque analysis software ()
Evoque TTVR system linked to favorable outcomes in new real-world analysis ()
First-in-human data highlight IVL’s potential to treat more challenging lesions ()
Medicare now covers renal denervation for patients with uncontrolled hypertension ()
Clinical trials paused due to heart patient’s hospitalization ()
Cardiologist seeks answers about Trump’s health after MRI ()
New drug recall includes more than 140K bottles of popular statin ()
PARTNER 3 update: TAVR still comparable to SAVR in low-risk patients after 7 years ()
CRF merges with Fogarty Innovation to take healthcare innovation to the next level ()
A promising SELUTION: Sirolimus-eluting balloon from Cordis makes impression at TCT 2025 ()
Medtronic launches FDA-cleared guidewire compatible with multiple TAVR systems ()
The push to get 3D echo into the congenital operating room ()
P‐waves can help identify Black patients prone to developing AFib ()
Poor oral health tied to much higher risk of heart attack, stroke ()
Transcatheter heart failure implant from Ancora Heart linked to positive 2-year data ()
'The less you drink, the better': Even minor changes in alcohol use lower hypertension risk ()
New biodegradable PFO closure device shows early potential ()
Cardiology groups among the voices concerned about more medical device tariffs ()
Collaborations, guidelines and grants: ASNC shares big plans for 2026 ()
New Heartflow tech delivers AI-powered PCI planning for cardiologists ()
PCI for eruptive calcified nodules: Drug-eluting stents, drug-coated balloons both linked to poor outcomes ()
ASE leading push to revise CPT code for interventional echocardiography ()
Cardiology leader, a ’40 under 40’ winner, arrested for leaving baby on beach ()
Medtronic announces new AI partnership focused on improving TAVR care ()
Judge files lawsuit over husband’s death—alleges heart symptoms were mismanaged ()
FDA confirms Class I recall for Johnson & Johnson devices due to durability concerns ()
Nuclear cardiology expands beyond perfusion imaging as it enters a new era ()
How clinicians can combat health disparities in cardio-oncology ()
Most adults know nothing about CKM syndrome—but it impacts nearly everyone ()
FDA approves oral semaglutide for reducing cardiovascular risks in adults with type 2 diabetes ()
PET holds promise for carotid plaque assessments ()
New-onset AFib is common after CABG—but typically not persistent or symptomatic ()
Hospital in Mexico earns first heart failure certification of its kind ()
Hypertrophic Cardiomyopathy Association supports study of potential treatment for nonbstructive HCM ()
SGLT2 inhibitors after TAVR may boost survival, limit bioprosthetic valve dysfunction ()
Field Medical’s PFA system for ventricular tachycardia shows early potential ()
Advances in imaging could help predict, prevent heart attacks ()
FDA clears AI-powered vascular imaging software ()
A new era of electrophysiology: Accelerating innovation for AFib with pulsed field ablation ()
Cardiologist compensation hits an all-time high ()
Medtech companies working together on robotic PFA system ()
How PET is transforming cardiac nuclear imaging ()
Performing PCI and TAVR together may improve in-hospital outcomes, long-term survival ()
How mental health can influence cardiovascular health ()
Cardiologists perform first TTVR of its kind on recent heart transplant recipient ()
Long-term data highlight Ross procedure's safety, effectiveness in younger patients ()
FDA approves labeling changes for fenofibrates due to lack of cardiovascular benefits ()
Coronary CTA and Plaque Analysis: From Imaging to Action ()
FDA approves key update for Medtronic’s Endurant stent graft system ()
Q&A: What cardiologists know and don’t know about pulsed field ablation ()
FDA details Class I recalls for more than 1 million pacemakers—software update required ()
Medtronic launches full distribution of new 3-in-1 carotid stent ()
Plant-based diets linked to lower dementia risk for vulnerable heart patients ()
Common methods for attributing cardiac care in ACOs may be falling short ()
FDA announces recall for Johnson & Johnson devices due to cybersecurity risk—customers urged to act ()
Florida patient sues hospital, cardiology practice for alleged negligence after leg amputation ()
FDA approves Zoll's newest defibrillator-monitor ()
New expert guidelines examine the use of temporary MCS during heart surgery ()
Multimodality imaging is more important than ever to the field of cardio-oncology ()
FDA approves subcutaneous diuretic treatment for heart failure-related edema ()
‘Every second counts’: New Viz.ai platform brings the entire heart attack team together ()
Pushback against Trump's $100K visa fee continues with new lawsuit ()
FDA clears new AI model for MAC detection in routine imaging results ()
Cardiologist dies after choking on flight—family’s lawsuit points to alleged negligence ()
SCAI highlights the benefits of ICE-guided structural heart interventions ()
AI-powered cardiac mapping system gains an important approval ()
Obesity drugs under review: Semaglutide, tirzepatide, naltrexone/bupropion all boost heart health ()
Ultrasound renal denervation: A high-value treatment option for patients with uncontrolled hypertension ()
ACC urges Congress to restore telemedicine flexibilities ()
ASE 2025 delivered a fully immersive experience for cardiovascular ultrasound professionals ()
The best children’s heart hospitals in the US ()
From heart pumps to politics: Former medtech CEO launches campaign to be the governor of Massachusetts ()
DAPT during valve-in-valve TAVR may reduce stroke risk—more data still required ()
How to take your CCTA program to the next level ()
The universal screening of children for familial hypercholesterolemia can save lives ()
Impella heart pump provides value during high-risk PCI, meta-analysis confirms ()
Cardiologists, heart surgeons sound alarm over widespread use of TAVR in low-risk patients ()
Trump's $100K visa fee will be bad for heart patients ()
Heart surgeon under investigation after deaths—colleagues questioned her judgement ()
Medtronic gains key approval for LAA exclusion device ()
Tracking the long-term safety of performing SAVR, other heart surgeries after TAVR ()
ACC calls for more screening in new scientific statement on inflammation ()
Next-generation Watchman enters trial in 2026 as LAAO volume grows ()
ACC and AHA outline calculation of cost-effectiveness in clinical practice guidelines ()